24/7 Wall Street
25 Oct 2026, 16:00 UTC · 2h ago
Rocket Lab Is Playing a Much Bigger Game Than Rocket Launches
Impact · against what's priced in
The primary catalyst is the further delay of the Neutron rocket to 2027, which heightens the risk of equity dilution before commercial launch. While the Iridium acquisition and backlog growth are strong, these are already accounted for in the current valuation and do not provide immediate upside.
- RKLB−0.40
Challenges what's priced in
- The price assumes
The Neutron rocket achieving operational milestones





